Abiopharma

News list

Matsuda Kazuko 🟢 acquired 350.0K shares (1 derivative) of MEDICINOVA INC (MNOV) at $2.10 Transaction Date: Jan 16, 2026 | Filing ID: 000430

Full text

News bot Jan. 29, 2026, 2:21 p.m.
🔍 Matsuda Kazuko (Executive)

Company: MEDICINOVA INC (MNOV)

Report Date: 2026-01-16
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 350,000
Detailed Transactions and Holdings:
- Acquired 350,000 shares of Employee Stock Option (Right to Buy) at $2.1 per share (Derivative)
  Date: 2026-01-16 | Code: A | Expires: 2035-01-06 | Exercise: 2026-01-16 | equity_swap_involved: 0 | shares_owned_after: 350,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: On January 7, 2025, the reporting person was granted an option to purchase 350,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2025. Such performance criteria for 2025 were met, resulting in full vesting of the option.